Cleared Traditional

K950354 - HUMAN CHORIONIC GONADOTROPIN (HCG) TEST SYSTEM FOR THE EARLY DETECTION OF PREGNANCY

K950354 is an FDA 510(k) clearance for HUMAN CHORIONIC GONADOTROPIN (HCG) TEST..., manufactured by Ml Strategies, Inc.. The device is a Class 2 Chemistry device with product code LCX cleared through the Traditional 510(k) pathway after a 170-day FDA review.

K950354 · Ml Strategies, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1995
Decision
170d
Days
Class 2
Risk

K950354 is an FDA 510(k) clearance for the HUMAN CHORIONIC GONADOTROPIN (HCG) TEST SYSTEM FOR THE EARLY DETECTION OF PRE.... Classified as Kit, Test, Pregnancy, Hcg, Over The Counter (product code LCX), Class II - Special Controls.

Submitted by Ml Strategies, Inc. (Boston, US). The FDA issued a Cleared decision on July 19, 1995 after a review of 170 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K950354

510(k) Number K950354 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 30, 1995
Decision Date July 19, 1995
Days to Decision 170 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d slower than avg
Panel avg: 88d · This submission: 170d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LCX Device Classification - Class 2, Special Controls

Product Code LCX Kit, Test, Pregnancy, Hcg, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - LCX Kit, Test, Pregnancy, Hcg, Over The Counter

All 202
Devices cleared under the same product code (LCX) and FDA review panel - the closest regulatory comparables to K950354.
SELFCARE EARLY PREGNANCY TEST
K955903 · Cambridge Diagnostics Ireland, Ltd. · Mar 1996
OSOM PREGNANCY TEST
K954178 · Wyntek Diagnostics, Inc. · Oct 1995
CAMEO HOME PREGNANCY TEST
K954364 · Quidel Corp. · Oct 1995
LIFESIGN(TM) 1, BIOSIGN(TM) 1, LIFESIGN PLUS(TM), LIFESIGN(TM) HCG
K945514 · Princeton BioMeditech Corp. · Feb 1995
ADVANCE(R) PREGNANCY TEST
K945846 · Advanced Care Products · Jan 1995
HCG MIDSTREAM PREGNANCY TEST
K945568 · Mizuho USA, Inc. · Jan 1995
K950354 · HUMAN CHORIONIC GONADOTROPIN (HCG) TEST SYSTEM FOR THE EARLY DETECTION OF PREGNANCY
Download PDF Ml Strategies, Inc.